DGAP-Ad-hoc: AlzChem Group AG / Key word(s): Change in Forecast AlzChem Group AG raises forecast 2021 due to very positive business development 15-Jul-2021 / 18:31 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. =---------------------------------------------------------------------------------------------------------------------- AlzChem Group AG raises forecast 2021 due to very positive business development Trostberg, July 15, 2021 - Based on preliminary figures, AlzChem Group AG recorded a very positive business development in the first half of 2021 that was significantly above plan. Group sales improved year-on-year from EUR 197.3 million to EUR 215.3 million. This was due to the stronger than expected recovery in the automotive and steel industries, as well as very good sales successes in dietary supplements and renewable energies. Due to the strong focus of customers on a European supply chain, AlzChem was able to take advantage of additional business opportunities with its broad product portfolio. Despite highly volatile raw material markets, significantly rising electricity and CO[2] certificate costs, and an unfavorable USD exchange rate, earnings before interest, taxes, depreciation and amortization (EBITDA) rose to a record level of EUR 35.7 million (previous year: EUR 29.1 million). Consequently, the EBITDA margin increased to 16.6% (previous year: 14.8%). The equity ratio was 22.4% as of June 30, 2021 (December 31, 2020: 19.4%). Due to the very positive business development in the first half of 2021, AlzChem Group AG is raising its forecast for the full year 2021 as follows: Key figure 2020 Original forecast 2021 New forecast 2021 Sales EUR 379.3 slightly increasing to increasing Significantly to strongly million (up to EUR 400 million) increasing (up to EUR 415 million) EBITDA EUR 53.8 million stable to slightly increasing (up to EUR 57 Significantly to rapidly increasing million) (up to EUR 64 million) EBITDA margin 14.2% slightly declining to stable stable to slightly increasing Inventory ratio 19.0% very slightly increasing to stable slightly to noticeably decreasing Equity ratio 19.4% stable to slightly increasing moderately to slightly increasing
The new forecast is based on the assumption that the economic recovery will continue unchanged, that there will be no negative impact on the raw material pipeline, and that there will be no more severe restrictions due to the Corona pandemic in the second half of 2021.
The detailed half-year financial report 2021 will be available for download on the website www.alzchem.com under Investor Relations/Publications/Financial Reports on Thursday, August 5, 2021. Contact: Sabine Sieber Head of Investor Relations & Communications -----------------------------------------------------------------------------------------------------------------------
15-Jul-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de -----------------------------------------------------------------------------------------------------------------------
Language: English Company: AlzChem Group AG Dr.-Albert-Frank-Str. 32 83308 Trostberg Germany Phone: +498621862888 Fax: +49862186502888 E-mail: ir@alzchem.com Internet: www.alzchem.com ISIN: DE000A2YNT30 WKN: A2YNT3 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart EQS News ID: 1219391 End of Announcement DGAP News Service =------------
1219391 15-Jul-2021 CET/CEST
Image link:
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1219391&application_name=news
(END) Dow Jones Newswires
July 15, 2021 12:32 ET (16:32 GMT)